Literature DB >> 34395778

CRISPR/Cas Gene Editing of a Large DNA Virus: African Swine Fever Virus.

Manuel V Borca1, Keith A Berggren1,2, Elizabeth Ramirez-Medina1,3, Elizabeth A Vuono1,2, Douglas P Gladue1.   

Abstract

Gene editing of large DNA viruses, such as African swine fever virus (ASFV), has traditionally relied on homologous recombination of a donor plasmid consisting of a reporter cassette with surrounding homologous viral DNA. However, this homologous recombination resulting in the desired modified virus is a rare event. We recently reported the use of CRISPR/Cas9 to edit ASFV. The use of CRISPR/Cas9 to modify the African swine fever virus genome resulted in a fast and relatively easy way to introduce genetic changes. To accomplish this goal we first infect primary swine macrophages with a field isolate, ASFV-G, and transfect with the CRISPR/Cas9 donor plasmid along with a plasmid that will express a specific gRNA that targets our gene to be deleted. By inserting a reporter cassette, we are then able to purify our recombinant virus from the parental by limiting dilution and plaque purification. We previously reported comparing the traditional homologous recombination methodology with CRISPR/Cas9, which resulted in over a 4 log increase in recombination.
Copyright © 2018 The Authors; exclusive licensee Bio-protocol LLC.

Entities:  

Keywords:  ASF; ASFV; African swine fever; CRISPR; CRISPR/Cas9

Year:  2018        PMID: 34395778      PMCID: PMC8328649          DOI: 10.21769/BioProtoc.2978

Source DB:  PubMed          Journal:  Bio Protoc        ISSN: 2331-8325


  10 in total

1.  Titration of African swine fever (ASF) virus.

Authors:  L Enjuanes; A L Carrascosa; M A Moreno; E Viñuela
Journal:  J Gen Virol       Date:  1976-09       Impact factor: 3.891

2.  African Swine Fever Virus Georgia 2007 with a Deletion of Virulence-Associated Gene 9GL (B119L), when Administered at Low Doses, Leads to Virus Attenuation in Swine and Induces an Effective Protection against Homologous Challenge.

Authors:  Vivian O'Donnell; Lauren G Holinka; Peter W Krug; Douglas P Gladue; Jolene Carlson; Brenton Sanford; Marialexia Alfano; Edward Kramer; Zhiqiang Lu; Jonathan Arzt; Bo Reese; Consuelo Carrillo; Guillermo R Risatti; Manuel V Borca
Journal:  J Virol       Date:  2015-06-10       Impact factor: 5.103

3.  An African swine fever virus virulence-associated gene NL-S with similarity to the herpes simplex virus ICP34.5 gene.

Authors:  L Zsak; Z Lu; G F Kutish; J G Neilan; D L Rock
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

Review 4.  African swine fever virus.

Authors:  E R Tulman; G A Delhon; B K Ku; D L Rock
Journal:  Curr Top Microbiol Immunol       Date:  2009       Impact factor: 4.291

5.  Live attenuated pseudorabies virus developed using the CRISPR/Cas9 system.

Authors:  Yan-Dong Tang; Ji-Ting Liu; Tong-Yun Wang; Tong-Qing An; Ming-Xia Sun; Shu-Jie Wang; Qiong-Qiong Fang; Lin-Lin Hou; Zhi-Jun Tian; Xue-Hui Cai
Journal:  Virus Res       Date:  2016-09-13       Impact factor: 3.303

6.  A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors.

Authors:  Ming Yuan; Pengju Wang; Louisa S Chard; Nicholas R Lemoine; Yaohe Wang
Journal:  J Vis Exp       Date:  2016-10-30       Impact factor: 1.355

Review 7.  CRISPR/Cas9-Advancing Orthopoxvirus Genome Editing for Vaccine and Vector Development.

Authors:  Arinze Okoli; Malachy I Okeke; Morten Tryland; Ugo Moens
Journal:  Viruses       Date:  2018-01-22       Impact factor: 5.048

8.  Engineering large viral DNA genomes using the CRISPR-Cas9 system.

Authors:  Tadahiro Suenaga; Masako Kohyama; Kouyuki Hirayasu; Hisashi Arase
Journal:  Microbiol Immunol       Date:  2014-09       Impact factor: 1.955

9.  A marker-free system for highly efficient construction of vaccinia virus vectors using CRISPR Cas9.

Authors:  Ming Yuan; Xuefei Gao; Louisa S Chard; Zarah Ali; Jahangir Ahmed; Yunqing Li; Pentao Liu; Nick R Lemoine; Yaohe Wang
Journal:  Mol Ther Methods Clin Dev       Date:  2015-09-16       Impact factor: 6.698

10.  CRISPR-Cas9, a tool to efficiently increase the development of recombinant African swine fever viruses.

Authors:  Manuel V Borca; Lauren G Holinka; Keith A Berggren; Douglas P Gladue
Journal:  Sci Rep       Date:  2018-02-16       Impact factor: 4.379

  10 in total
  11 in total

1.  Deletion of the A137R Gene from the Pandemic Strain of African Swine Fever Virus Attenuates the Strain and Offers Protection against the Virulent Pandemic Virus.

Authors:  Douglas P Gladue; Elizabeth Ramirez-Medina; Elizabeth Vuono; Ediane Silva; Ayushi Rai; Sarah Pruitt; Nallely Espinoza; Lauro Velazquez-Salinas; Manuel V Borca
Journal:  J Virol       Date:  2021-08-18       Impact factor: 5.103

2.  Deletion of the H108R Gene Reduces Virulence of the Pandemic Eurasia Strain of African Swine Fever Virus with Surviving Animals Being Protected against Virulent Challenge.

Authors:  Elizabeth Vuono; Elizabeth Ramirez-Medina; Ediane Silva; Ayushi Rai; Sarah Pruitt; Nallely Espinoza; Alyssa Valladares; Lauro Velazquez-Salinas; Douglas P Gladue; Manuel V Borca
Journal:  J Virol       Date:  2022-07-06       Impact factor: 6.549

3.  Deletion of African Swine Fever Virus Histone-like Protein, A104R from the Georgia Isolate Drastically Reduces Virus Virulence in Domestic Pigs.

Authors:  Elizabeth Ramirez-Medina; Elizabeth A Vuono; Sarah Pruitt; Ayushi Rai; Nallely Espinoza; Alyssa Valladares; Ediane Silva; Lauro Velazquez-Salinas; Manuel V Borca; Douglas P Gladue
Journal:  Viruses       Date:  2022-05-22       Impact factor: 5.818

4.  Serum Neutralizing and Enhancing Effects on African Swine Fever Virus Infectivity in Adherent Pig PBMC.

Authors:  Jessica A Canter; Theresa Aponte; Elizabeth Ramirez-Medina; Sarah Pruitt; Douglas P Gladue; Manuel V Borca; James J Zhu
Journal:  Viruses       Date:  2022-06-09       Impact factor: 5.818

5.  Deletion of E184L, a Putative DIVA Target from the Pandemic Strain of African Swine Fever Virus, Produces a Reduction in Virulence and Protection against Virulent Challenge.

Authors:  Elizabeth Ramirez-Medina; Elizabeth Vuono; Ayushi Rai; Sarah Pruitt; Nallely Espinoza; Lauro Velazquez-Salinas; Sonia Pina-Pedrero; James Zhu; Fernando Rodriguez; Manuel V Borca; Douglas P Gladue
Journal:  J Virol       Date:  2021-10-20       Impact factor: 6.549

6.  Evaluation of the Safety Profile of the ASFV Vaccine Candidate ASFV-G-ΔI177L.

Authors:  Xuan Hanh Tran; Le Thi Thu Phuong; Nguyen Quang Huy; Do Thanh Thuy; Van Dung Nguyen; Pham Hào Quang; Quách Võ Ngôn; Ayushi Rai; Cyril G Gay; Douglas Paul Gladue; Manuel Victor Borca
Journal:  Viruses       Date:  2022-04-25       Impact factor: 5.818

7.  Construction of BHV-1 UL41 Defective Virus Using the CRISPR/Cas9 System and Analysis of Viral Replication Properties.

Authors:  Haiyue Dai; Jianan Wu; Hongshu Yang; Yongli Guo; Haoqing Di; Mingchun Gao; Junwei Wang
Journal:  Front Cell Infect Microbiol       Date:  2022-07-08       Impact factor: 6.073

8.  Deletion of the ASFV dUTPase Gene E165R from the Genome of Highly Virulent African Swine Fever Virus Georgia 2010 Does Not Affect Virus Replication or Virulence in Domestic Pigs.

Authors:  Elizabeth A Vuono; Elizabeth Ramirez-Medina; Sarah Pruitt; Ayushi Rai; Nallely Espinoza; Ediane Silva; Lauro Velazquez-Salinas; Douglas P Gladue; Manuel V Borca
Journal:  Viruses       Date:  2022-06-28       Impact factor: 5.818

9.  ASFV Gene A151R Is Involved in the Process of Virulence in Domestic Swine.

Authors:  Elizabeth Ramirez-Medina; Elizabeth Vuono; Sarah Pruitt; Ayushi Rai; Nallely Espinoza; Alyssa Valladares; Edward Spinard; Ediane Silva; Lauro Velazquez-Salinas; Douglas P Gladue; Manuel V Borca
Journal:  Viruses       Date:  2022-08-21       Impact factor: 5.818

10.  Evaluation of an ASFV RNA Helicase Gene A859L for Virus Replication and Swine Virulence.

Authors:  Elizabeth Ramirez-Medina; Elizabeth A Vuono; Sarah Pruitt; Ayushi Rai; Nallely Espinoza; Lauro Velazquez-Salinas; Douglas P Gladue; Manuel V Borca
Journal:  Viruses       Date:  2021-12-21       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.